ReNAgade Therapeutics Funding: $300M Raised, Series A (2023)

ReNAgade Therapeutics is based in Cambridge, Massachusetts. It has raised $300M in total funding. Latest round: Series A.

ReNAgade Therapeutics funding overview

ReNAgade Therapeutics is based in Cambridge, Massachusetts. ReNAgade Therapeutics has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in May 2023. The round record for ReNAgade Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include MPM BioImpact, F2 Ventures. 2 distinct backers are named across the disclosed rounds.

ReNAgade Therapeutics at a glance

Total raised
$300M
Latest round
Series A
Latest round date
May 2023
Headquarters
Cambridge, Massachusetts
Notable investors
MPM BioImpact, F2 Ventures

Frequently asked about ReNAgade Therapeutics funding

How much has ReNAgade Therapeutics raised?
ReNAgade Therapeutics has raised $300M in total disclosed funding across the rounds on record.
Who has invested in ReNAgade Therapeutics?
MPM BioImpact, F2 Ventures are named among the investors backing ReNAgade Therapeutics.
What was the latest ReNAgade Therapeutics funding round?
The most recent disclosed round is a Series A, announced in May 2023.
Where is ReNAgade Therapeutics based?
ReNAgade Therapeutics is based in Cambridge, Massachusetts.
When did ReNAgade Therapeutics last raise?
The last disclosed ReNAgade Therapeutics round closed in May 2023 at Series A.

Every ReNAgade Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.

Companies related to ReNAgade Therapeutics (24)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026